Non-myeloid Malignancies
📧 Sign up to get email alerts when something new happens for Non-myeloid Malignancies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2025-03-03Clinical Trial Update: Study of SSS06 for Chemotherapy-Induced Anemia in Non-Myeloid Malignancies [Phase 2]
Notes a Phase 2 trial of SSS06 for chemotherapy-induced anemia in non-myeloid malignancies, sponsored by Shenyang Sunshine Pharmaceutical Co…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) as Mono Therapy (Without Erythropoiesis Stimulating Agents) in Comparison With Oral Iron Sulfate in Subjects With Non-myeloid Malignancies Associated With Chemotherapy Induced Anaemia (CIA) [Phase 3]
Phase 3 trial comparing intravenous iron isomaltoside 1000 (Monofer) as monotherapy to oral iron sulfate for chemotherapy-induced anemia in …
-
CLINICAL_TRIALS trial_result · 2014-01-29Clinical Trial Update: Darbepoetin Alfa With or Without Intravenous (IV) Iron [Phase 2]
This Phase 2 trial evaluated darbepoetin alfa with or without intravenous iron for anemia in patients with non-myeloid malignancies. The stu…
-
CLINICAL_TRIALS trial_result · 2013-04-29Clinical Trial Update: A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy [Phase 3]
Phase 3 clinical trial evaluating darbepoetin alfa for treating anemia in patients with non-myeloid malignancies receiving multi-cycle chemo…
-
CLINICAL_TRIALS research · 2008-02-28Clinical Trial Update: Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy [Phase 3]
Phase 3 clinical trial evaluating treatment for patients with non-myeloid malignancies receiving chemotherapy has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.